Latest News

Experimental drug reduces brain damage, eliminates brain hemorrhaging in rodents afflicted by stroke

The experimental drug 3K3A-APC shows promise as a stand-alone therapy for stroke or in combination with the FDA-approved clot-busting drug therapy tPA (tissue plasminogen activator).
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • DNA signature in Ice Storm babies: Prenatal maternal stress exposure to natural disasters predicts epigenetic profile of offspring

  • Chefs at schools can increase school meal participation, vegetable intake among students

  • Improving babies' language skills before they're even old enough to speak

  • After-school exercise program enhances cognition in 7-, 8- and 9-year-olds

  • How career dreams are born

  • Who are the men, boys suffering from anorexia?

  • Feeling fatigued while driving? Don't reach for your music

  • New clues revealed to understand brain stimulation

  • What makes a song sing? Backup singers

  • Transplant drug could boost power of brain tumor treatments, study finds

  •